The role of mitochondrial DNA (mtDNA) variant 16189T>C in type 2 diabetes mellitus (T2DM) remains hotly debated in the past decade. If mutation 16189T>C indeed posed a risk to T2DM, as echoed by some recent studies, correlation between this mutation and disease should be observed when carrying out a systematical study using data and samples collected in a large geographic region in China. To test this hypothesis, we first performed a linear regression analysis between the prevalence of T2DM and the allele frequency of 16189C variant in 10 East Asian populations, and further genotyped this variant in two casecontrol cohorts from west Han Chinese (Kunming and Xining). Linear regression analysis showed that no significant correlation was observed (r 2 =0.211, P=0.181), and the genotyping results indicated that the m.16189T>C frequency difference between case and control was not significant in either populations (P=0.38 and 0.89 for Kunming and Xining, respectively). Matrilineal backgrounds constitution (in terms of haplogroups) analysis generated a similar haplogroup distribution in both populations (P>0.1). All results failed to substantiate that m.16189T>C may play an active role in the development of T2DM in East Asian populations.
INTRODUCTION
Type 2 diabetes mellitus (T2DM) is a common metabolic disorder and has been recognized as a global health problem nowadays, which is supposed to affect more than 300 million individuals worldwide by 2025 [1] . However, the exact mechanisms underlying the development and progression of T2DM still remain unclear. Due to the facts that mitochondrial oxidative phosphorylation (OXPHOS) plays an important role in glucose simulated insulin secretion by beta cells [2] , and that some T2DM patients present a maternal inherited pattern [3] , it has then been speculated that some mutations on mitochondrial DNA (mtDNA) may contribute to the onset of T2DM. One example is mtDNA 3243 A>G mutation, which has been proven to impair the cellular metabolic pathways in beta cells [4] .
*Address correspondence to this author at the State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, China; Tel: (+86) 871-6519 9030; Fax: (+86) 871-6519 5430; E-mails: kongqp@mail.kiz.ac.cn (Q-P K) or zhangyp@mail.kiz.ac.cn (Y-P Z) One common variant in mtDNA control-region, m.16189T>C, which triggers the length variation of Cstretch in region 16184-16193, was suggested to be associated with T2DM in United Kingdom [5, 6] and East Asia [7] [8] [9] [10] . However, the association could not be replicated by the subsequent studies on UK populations [11, 12] , emphasizing the necessity of further studies to put deeper insights into this issue. If m.16189T>C does confer susceptibility to T2DM, it would be expected that the prevalence of this disease should in general be associated positively with the distribution frequency of 16189C across different populations in a region. However, the potential correlation between these two important indexes has never been investigated.
Human mtDNAs can be classified into various haplogroups based on some specific variants inherited from the most recent common (matrilineal) ancestor [13, 14] , and the m.16189T>C serves as one of the specific mutations for some well-characterized haplogroups, such as X, T1, and U2e in West Eurasian and B and D5 in East Eurasian [13, 14] . If m.16189T>C does confer susceptibility to T2DM, some special mtDNA haplogroups, especially those characterized by this variant, should naturally be expected to present higher frequency in the samples with T2DM than that in healthy controls. In contrast, supposing that m.16189T>C is a neutral polymorphism, the observed haplogroup distribution in T2DM patients may actually mirror the specific haplogroup(s) background.
In present study, we first retrieved m.16189T>C frequencies and T2DM prevalence data in 10 East Asian populations from literatures and performed a linear regression analysis to test correlations between them. Moreover, we genotyped m.16189T>C in two west Chinese Han case-control populations and compared their frequencies and haplogroup constitution, with a special attempt to assess the matrilineal background effect on the onset of T2DM. No significant results were obtained, which suggested that m.16189T>C is likely a benign variant rather than a pathogenic one. Our study provided new insights into the role m.16189T>C in T2DM development and substantiated the importance of performing exhaustive analysis in the disease study.
MATERIALS AND METHODS

Frequency Data Mining and Analysis
The mtDNA control region re-sequencing data were collected for East Asian populations from Hangzhou [15] , Xi'an [15, 16] , Shanghai [15] , Xi'ning [15] , Dalian [15] , Nanjing [15] , Changsha [15, 16] , Taiwan [17] , Korea [18] , and Japan [19] , among which the distribution frequencies of m.16189T>C were counted respectively. The prevalence data of T2DM for each population were retrieved from literatures [20] [21] [22] [23] [24] [25] [26] [27] [28] with some published in Chinese [20] [21] [22] [23] [24] [25] .
Case-Control Populations
Two case-control cohorts from west Han Chinese were collected. Kunming cohort (Yunnan, southwest China) contained 593 unrelated patients with T2DM that were diagnosed according to the criteria recommended by the World Health Organization at the First Affiliated Hospital of Kunming Medical University and 277 age-matched healthy Han subjects from the same area. The 43 Han samples from Kunming, Yunnan Province published in Yao et al. [29] were also included in the analysis as controls. We also collected 228 T2DM patients and 191 healthy control subjects in Xining (Qinghai, northwest China) as a second cohort. This study was approved by the ethics committee of Yunnan University and informed consent was obtained from all donors.
DNA Extraction and Amplification
The genomic DNA was extracted from peripheral blood by standard phenol/chloroform method. Hypervariable segment I (HVS-I), which contained the m.16189T>C, was amplified in all samples by using the primer pair L15996 (5'-CTCCACCATTAGCACCCAA AGC-3')/H16201 (5'-GGTTGATTG CTGTACTTGCTT G -3'). PCR reaction was performed under the following condition: 94°C for 2 minutes, 35 cycles of 94°C for 40 seconds, 60°C for 1 minute and 72°C for 1 minute, then ended with incubation at 72°C for 5 minutes. Each fragment was digested by endonuclease Mnl1. Wildtype mtDNA would yield two fragments while mtDNA with mutation would generate only one, which could be distinguished on 3% agarose gel. All samples with m.16189T>C were further amplified with the primer pair L15996/H16498 [29] , and re-sequenced by using the BigDye TM Terminator Cycle Sequencing kit (Applied Biosystems, USA) on an ABI PRISM 3700 sequencer (Applied Biosystems).
Data Analysis
Sequences were edited and aligned by DNAStar software (DNAStar Inc., USA), and variants were recorded according to the revised Cambridge Reference Sequence [30] . All mtDNAs with 16189T>C were tentatively classified into respective haplogroups according to the updated East Asian mtDNA phylogenetic tree [14] . Their haplogroup classifications were further substantiated by detecting additional codingregion variation(s) as fully described in our previous studies [29] .
Statistical Analysis
Statistical analyses were performed by using SPSS 13.0 (SPSS Inc., USA). Linear regression was used to evaluate the association between the prevalence of T2DM and m.16189T>C frequency. The frequencies of m.16189T>C in the case and control groups were compared by the χ 2 test (with Yates' correction for 2×2 contingency tables). Relative risk associated with the m.16189T>C was estimated by the odd ratio (OR). Statistical significance was accepted when P<0.05. The association between matrilineal background (viz. haplogroup) and T2DM was assessed by the χ 2 test or fisher's exact test and the minimum false discovery rate (FDR) for each test was estimated with QVALUE (http://faculty.washington.edu/~jstorey/qvalue/) [31] . An FDR < 0.05 was regarded as a significant result.
RESULTS
The correlation analysis between the prevalence of T2DM and the allele frequency of 16189C was shown in Fig. (1) . The T2DM prevalence in the 10 East Asian populations ranged from 3.05% in Xi'an, China, to 10.1% in Japan. The average m.16189T>C frequency was 29.6%, with highest in Korean (33.9%) and lowest in Changsha, China (20.4%). When linear regression was performed, no significant association was observed (Pearson r 2 =0.211, P=0.181), and thus failed to support the hypothesis. However, several cautions should be noted when discussing this result. For Taiwan Han Chinese, the prevalence of T2DM was estimated for Tainan city [26] , while the mtDNAs data was not exactly for this city but came from the whole Taiwan region [17] . A similar situation also appeared in the Japanese sample: the prevalence of T2DM was estimated for rural Japanese [28] , while the mtDNAs data was from the whole Japan [19] . After removing these two populations, the negative result still persisted (Pearson r 2 =0.182, P=0.292), despite of the fact that the correlation coefficient showed some association trend. Fig. (1) . Correlation between m.16189T>C frequency and T2DM prevalence in 10 East Asian populations. X-axis indicates the T2DM prevalence while Y-axis represents the percentage of m.16189T>C variant in corresponding region. Data were taken from literatures [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] .
In order to further evaluate the contribution of m.16189T>C to T2DM, we compared m.16189T>C frequencies in two Chinese Han case-control populations (Kunming and Xining). The frequencies of m.16189T>C in T2DM patients and healthy controls in these two cohorts were shown in Table 1 . In Kunming Han population, the m.16189T>C frequency was a little higher in T2DM patients (185/593, 31.2%) than in normal controls (90/317, 28.4%), but the difference was not significant (OR 1.14, 95% CI 0.85-1.54, P=0.38). A similar pattern was observed in the Xining Han population (26.8% in case and 26.2% in control respectively; OR 1.03, 95% CI 0.67-1.59, P=0.89). The result was not changed when we combined the two populations for analysis (30.0% in case and 27.5% in control respectively; OR 1.12, 95% CI 0.88-1.44, P=0. 35) . All these result suggested that m.16189T>C was not likely to contribute to T2DM risk, despite of the fact that the sample size was a little bit small.
We further classified these mtDNAs with m.16189T>C into respective haplogroups and attempted to discern the potential contribution of matrilineal background to T2DM. Haplogroup distribution of samples harboring m.16189T>C was compared in case and control cohorts ( Table 2) . Among the 386 mtDNAs with m.16189T>C that were distilled from 1,329 subjects, a total of 18 haplogroups were identified, in which the majority (70.0%; Tables S1-S4) are the haplogroups with diagnostic m.16189T>C (in combination with some other specific variants), such as B, D5, F1b, and M7b2. The occurrence of m.16189T>C in other haplogroups could be attributable to parallel mutation event ---an observation that was in accordance with the hypervariable character of the site [32] . No haplogroup showed significantly different frequency between T2DM and control (P>0.05) in both Kunming and Xining Han population, especially after a correction for multiple testing (FDR>0.90 and >0.85, respectively). In the combined set, haplogroup B showed slightly significant (P=0.03), but failed to pass multiple correction (FDR=0.63). These results suggested that matrilineal genetic background does not influence T2DM onset. 
DISCUSSION
T2DM is a complex metabolic disorder and its major etiology remains unknown. mtDNA is a suggested candidate factor of T2DM since mitochondria play an essential role in insulin secretion by pancreatic beta cells [33] . m.16189T>C in mtDNA control region was widely investigated for its association with T2DM, but no consistent conclusion has reached so far, even in the same (UK) populations [5, 11] . In the present study, we performed a systematical investigation using both epidemiologic and phylogenic approches, to evaluate the potential association between m.16189T>C and T2DM. All results, including association analysis between m.16189T>C frequency and T2DM prevalence, m.16189T>C frequency comparison in two case-control populations, and haplogroup distribution analysis, failed to support the association between the variant and T2DM susceptibility in East Asian populations.
Our results were different from those in previous studies on Asians [7] [8] [9] [10] . Besides genetic heterogeneity, sample size, and statistic power, sampling bias might be reasonable to explain this inconsistence. Essentially, m.16189T>C frequency varies substantially in a broad geographical area across East Asian. To substantiate this, we extended our m.16189T>C frequency analysis to 2,197 mtDNAs across East Asian, including Korean, Japan and 20 provinces in China [15-19, 29, 34] . Our results suggested that in East Asian populations, the 16189C frequencies were significantly different depending on the sampling regions, with highest value (52.2%) in Jiangxi Province, immediate value (29.9%) in Jiangsu Province, and lowest (6.7%) in Gansu Province. Moreover, haplogroup B, D5, F1b and M7b2 contributed mostly to m.16189T>C (>60%) in 17 different populations, and the total frequencies of these four haplogroups were also differently distributed across different populations, of which the lowest in Gansu Province (0.0%) and highest in Jiangxi Province (47.8%), following with the distribution of m.16189T>C in those populations (linear regression Pearson r 2 =0.76, P<0.001, data not shown). All these observation suggested that the fluctuation of 16189C frequency in different populations might mirror the distribution of these specific halogroups in those populations. Therefore, it is certainly not surprising that m.16189T>C shows considerably different frequencies across a broad geographical area. Before the conclusion is reached, it is indispensable to properly estimate the potential effect of population substructure, which easily caused spurious positive results, especially in evaluating the role of mtDNA variants in developing T2DM.
Alternatively, the observed conflicting relationships between m.16189T>C and T2DM in different ethnic groups could be attributable to the influence of mtDNA background. To shed more light on the potential contribution of matrilineal background(s) to the distribution of m.16189T>C and to evaluate the relationship between the relevant matrilineal genetic background and T2DM, further efforts on the determination of haplogroup affiliation in the subjects with m.16189T>C were carried out and the frequency of each haplogroup between the two groups of casecontrol samples was compared in this study. Although the power to detect T2DM with major mithochondrial DNA haplogroup (etc. haplgroup B) was modest (data not shown) [35] , our result failed to identify any specific haplogroups (viz. matrilineal background) showing preference in either patient or control samples in both Han regional populations, suggesting that there has no specific matrilineal background involved in the "penetrance" of m.16189T>C in the T2DM cohort. In summary, our investigation of the potential role of m.16189T>C in T2DM failed to confirm the correlation between either m.16189T>C or matrilineal background and T2DM, suggesting that m.16189T>C or its matrilineal background may play a subtle role in development of T2DM in Chinese Han population, and further studies are mandatory in the future to clarify this issue. 
ABBREVIATIONS
CONFLICT OF INTEREST
The authors declare that they have no conflict of interest. When the sequence information is not available, the items have been left blank. a Suffixes A, C, T, and G indicate transversion, "d" indicates deletions, and "+" indicates insertions. b "1"denotes the presence of the 9-bp (CCCCCTCTA) deletion in the COII/tRNALys intergenic region, "2"denotes non-deletion. c "-" and "+" denote the absence and presence of the restriction site respectively. * unassigned haplorgroups 
SUPPLEMENTARY MATERIAL Reappraising the Relationship Between Mitochondrial DNA Variant m.16189T>C and Type 2 Diabetes Mellitus in East Asian Populations
